EnrichR results Version 1
External LinkIdentified gene targets of deregulated miRNAs were used as input. Ontology and pathway GO terms with an adjusted p-value < 0.05 were considered significantly overrepresented
Export PNG
Download
Creators and Submitter
Views: 867
Created: 11th Jun 2021 at 09:29
TagsThis item has not yet been tagged.
AttributionsNone
Version History
Version 1 (earliest) Created 11th Jun 2021 at 09:29 by Julia Scheel
No revision comments
Related items
Projects: COVID-19 Disease Map, Molecular characterization and angiogenic properties of extracellular vesicles in healthy and preeclamptic amniotic fluid, Overexpression of microRNAs miR-25-3p, miR-185-5p and miR-132-3p in Late Onset Fetal Growth Restriction, Validation of Results and Study of the Biochemical Pathways Involved, Comparative Proteome Profile of Placental Sub-anatomical regions, The deregulated interplay of complement system and antioxidant activity as a driver of adverse pregnancy outcomes
Institutions: University of Rostock, Instituto de Investigación Sanitaria La Fe
https://orcid.org/0000-0002-0034-7755
The principal research aim of iPLACENTA is to improve our ability to study, model and visualise the placenta. This will contribute to developing diagnostic tests and therapies for pregnancy complications such as preeclampsia and intrauterine growth restriction (IUGR). Placental defects are thought to be the cause of many major pregnancy complications, such as preeclampsia and intra-uterine growth restriction. Preeclampsia affects between 5 and 8 out of every 100 pregnant women and claims the lives ...
Projects: Molecular characterization and angiogenic properties of extracellular vesicles in healthy and preeclamptic amniotic fluid, Overexpression of microRNAs miR-25-3p, miR-185-5p and miR-132-3p in Late Onset Fetal Growth Restriction, Validation of Results and Study of the Biochemical Pathways Involved, Comparative Proteome Profile of Placental Sub-anatomical regions, The deregulated interplay of complement system and antioxidant activity as a driver of adverse pregnancy outcomes
Web page: https://www.iplacenta.eu/
